reading retatrutide threads from 2024 and half of it aged badly
phase 2. That is the whole post, but I will justify it.
Everything else people worry about in c/glp1women is downstream of it. Titration speed, muscle cramps, the endless dose arguments — most of it resolves if you sort phase 2 out first, and almost nobody does.
I say this having got it wrong for 24 months. My hs-CRP was the thing that eventually made me pay attention, which is a stupid way to learn a lesson that was in the sidebar the whole time.
best — the order this archive was captured in
Crossposting this to c/sideeffects because the people who need it are not reading this community.
Tracking number removed. It identifies both ends of a shipment.
the dosing is steep, the muscle cramps reports are real, and nobody knows the human safety yet
[removed by moderator]
nobody should be giving this to anyone without extensive monitoring
[removed by moderator]
Disagree on that part. 98.7% and 96.2% on the same vial is normal.
the 1.0mg arm is different from 1.7mg, results do not transfer
Respectfully this is a sample of one presented as a finding.
TRIUMPH data is phase 2, not phase 3, smaller n and shorter
Yeah, phase 2 retatrutide is interesting but it is not comparable to phase 3 compounds.
nobody should be giving this to anyone without extensive monitoring
phase 2 numbers are not maintenance numbers, cite the trial
the 1.0mg arm is different from 0.5mg, results do not transfer
Research use material only, no human-use approval anywhere. Posts must describe what happened, not instruct strangers.
- 1Crossposting this to c/sideeffects because the people who need it are not…7 comments in this branch · started by u/kofi_balogun